Acadian Asset Management LLC Increases Stock Holdings in Indivior PLC $INDV

Acadian Asset Management LLC lifted its position in shares of Indivior PLC (NASDAQ:INDV) by 124.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 1,492,272 shares of the company’s stock after buying an additional 827,230 shares during the quarter. Acadian Asset Management LLC’s holdings in Indivior were worth $21,977,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in the business. Mirae Asset Global Investments Co. Ltd. increased its holdings in Indivior by 16.0% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,820 shares of the company’s stock valued at $71,000 after acquiring an additional 666 shares in the last quarter. Y Intercept Hong Kong Ltd increased its stake in shares of Indivior by 17.4% during the 2nd quarter. Y Intercept Hong Kong Ltd now owns 25,443 shares of the company’s stock worth $375,000 after purchasing an additional 3,769 shares in the last quarter. Amalgamated Bank purchased a new position in shares of Indivior during the 2nd quarter worth approximately $61,000. CTC Alternative Strategies Ltd. acquired a new position in shares of Indivior during the 1st quarter worth approximately $96,000. Finally, State of New Jersey Common Pension Fund D purchased a new stake in Indivior in the 2nd quarter valued at approximately $262,000. 60.33% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities analysts have weighed in on INDV shares. Zacks Research raised Indivior from a “hold” rating to a “strong-buy” rating in a research report on Monday, November 3rd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Indivior in a research note on Friday, October 31st. Craig Hallum reiterated a “buy” rating and set a $41.00 price objective on shares of Indivior in a research report on Friday, October 31st. Northland Securities set a $40.00 target price on shares of Indivior in a report on Friday, October 31st. Finally, Jefferies Financial Group assumed coverage on shares of Indivior in a research note on Tuesday, July 22nd. They set a “buy” rating and a $20.00 price target on the stock. Two analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $32.17.

Indivior Price Performance

NASDAQ INDV opened at $30.88 on Tuesday. The company has a market cap of $4.26 billion, a P/E ratio of 49.81 and a beta of 0.68. Indivior PLC has a 12 month low of $7.62 and a 12 month high of $32.42. The company has a 50-day moving average of $25.12 and a 200-day moving average of $19.20.

Indivior (NASDAQ:INDV) last released its earnings results on Thursday, October 30th. The company reported $0.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.34. Indivior had a net margin of 6.65% and a negative return on equity of 86.28%. The business had revenue of $314.00 million for the quarter, compared to analysts’ expectations of $257.66 million. Indivior has set its FY 2025 guidance at EPS. As a group, equities research analysts anticipate that Indivior PLC will post 1.22 EPS for the current year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.